BlackRock Amends Chemours Co. Stake, Remains Key Shareholder
Ticker: CC · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1627223
| Field | Detail |
|---|---|
| Company | Chemours Co (CC) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its Chemours Co. holdings, still a major player.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, indicating a change in their ownership of The Chemours Co. common stock as of December 31, 2023. This filing, Amendment No. 12, shows that BlackRock continues to be a significant institutional holder, which can provide a sense of stability for current and potential investors in Chemours Co. stock.
Why It Matters
Large institutional ownership by firms like BlackRock can signal confidence in a company's long-term prospects, potentially influencing other investors and providing a floor for the stock price.
Risk Assessment
Risk Level: low — This filing is a routine update from a large institutional investor and does not indicate any immediate negative or positive risk for the company.
Analyst Insight
Investors should note BlackRock's continued presence as a significant shareholder in Chemours Co., which can be a positive signal, but should also conduct their own due diligence on the company's fundamentals.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- The Chemours Co. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 24, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 12 (number) — the specific amendment number for this filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and '(Amendment No: 12)' in the filing.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., as stated under the 'FILED BY' section and 'COMPANY CONFORMED NAME: BlackRock Inc.'.
What is the subject company whose securities are being reported?
The subject company is The Chemours Co., identified by 'COMPANY CONFORMED NAME: Chemours Co' and 'Name of Issuer: CHEMOURS COMPANY'.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified in the filing under 'Date of Event Which Requires Filing of this Statement'.
What is the CUSIP number for the securities reported?
The CUSIP number for the Common Stock of The Chemours Co. is 163851108, as listed under 'CUSIP Number' in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding Chemours Co (CC).